Full Sail Capital, LLC Astrazeneca PLC Transaction History
Full Sail Capital, LLC
- $1.43 Billion
- Q1 2024
A detailed history of Full Sail Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Full Sail Capital, LLC holds 4,524 shares of AZN stock, worth $348,302. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,524
Previous 7,073
36.04%
Holding current value
$348,302
Previous $476,000
35.71%
% of portfolio
0.02%
Previous 0.04%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...